This session will aim to support all clinicians to understand the principles behind the new BTS/SIGN/NICE 2024 diagnostic pathway, and encourage PC clinicians to implement a robust diagnostic pathway, aiming to confirm (or indeed negate) an accurate and timely asthma diagnosis for all patients, and subsequently embed the new BTS/SIGN/NICE 2024 approach towards the optimal and effective long-term management of the underlying pathobiology of asthma.
